SCHEMBL4247787

SCHEMBL4247787

O=C(O)c1cn(C2CC2)c2nc(N3CC=CC3)c(F)cc2c1=O

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 6/20 0.68
CHRM2 P08172 1/20 0.60
DRD1 P21728 1/20 0.60
LMNA P02545 3/20 0.56
KDM4E B2RXH2 2/20 0.56
HSD17B10 Q99714 2/20 0.56
ABCC4 O15439 1/20 0.56
DHFR P00374 1/20 0.52
TOP2A P11388 4/20 0.50
TOP2B Q02880 4/20 0.50
CYP2C9 P11712 2/20 0.50
ATP6V1B2 P21281 1/20 0.50
TBXA2R P21731 1/20 0.50
EDNRA P25101 1/20 0.50
TARBP2 Q15633 1/20 0.50
KMT2A Q03164 1/20 0.49
ALDH1A1 P00352 1/20 0.49
CYP1A2 P05177 1/20 0.49
HPGD P15428 1/20 0.49
EPHA2 P29317 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10377708 0.89 DPP4 (0.66) DPP4CHRM2DRD1LMNAKDM4E
SCHEMBL10377337 0.88 DPP4 (0.65) DPP4CHRM2DRD1LMNAKDM4E
SCHEMBL10377719 0.88 DPP4 (0.65) DPP4CHRM2DRD1LMNAKDM4E
SCHEMBL9757404 0.87 DPP4 (0.69) DPP4CHRM2DRD1LMNAKDM4E
SCHEMBL10874660 0.87 DPP4 (0.63) DPP4CHRM2DRD1LMNAKDM4E
SCHEMBL10377610 0.86 DPP4 (0.62) DPP4CHRM2DRD1LMNAKDM4E
SCHEMBL11022634 0.86 DPP4 (0.68) DPP4CHRM2DRD1LMNAKDM4E
SCHEMBL10377621 0.86 DPP4 (0.62) DPP4CHRM2DRD1LMNAKDM4E
SCHEMBL9522864 0.86 DPP4 (0.68) DPP4CHRM2DRD1LMNAKDM4E
SCHEMBL311935 0.86 LMNA (0.68) DPP4CHRM2DRD1LMNAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7902227-B2 C-7 isoxazolinyl quinolone / naphthyridine derivatives useful as antibacterial agents JANSSEN PHARMACEUTICA NV. (BE) 2011-03-08 US disclosed
US-7902227-B2 C-7 isoxazolinyl quinolone / naphthyridine derivatives useful as antibacterial agents JANSSEN PHARMACEUTICA NV. (BE) 2011-03-08 US disclosed
US-7902227-B2 C-7 isoxazolinyl quinolone / naphthyridine derivatives useful as antibacterial agents JANSSEN PHARMACEUTICA NV. (BE) 2011-03-08 US disclosed
WO-2010093341-A1 C-7 ISOXAZOLINYL QUINOLONE/NAPHTHYRIDINE DERIVATIVES USEFUL AS ANTIBACTERIAL AGENTS JANSSEN PHARMACEUTICA N.V. (BE) 2010-08-19 WO disclosed
US-20090029980-A1 C-7 Isoxazolinyl Quinolone / Naphthyridine Derivatives Useful as Antibacterial Agents JANSSEN PHARMACEUTICA N.V. (BE) 2009-01-29 US disclosed
US-20090029980-A1 C-7 Isoxazolinyl Quinolone / Naphthyridine Derivatives Useful as Antibacterial Agents JANSSEN PHARMACEUTICA N.V. (BE) 2009-01-29 US disclosed
US-20090029980-A1 C-7 Isoxazolinyl Quinolone / Naphthyridine Derivatives Useful as Antibacterial Agents JANSSEN PHARMACEUTICA N.V. (BE) 2009-01-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090029980-A1 C-7 Isoxazolinyl Quinolone / Naphthyridine Derivatives Useful as Antibacterial Agents CASP7, CYP3A7, NQO2 DPP4 491/4885CHRM2 4648/4885DRD1 1223/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.